SlideShare a Scribd company logo
Pathomics Based Biomarkers, Tools and
Methods
Joel Saltz
Department of Biomedical Informatics
Stony Brook University
Imaging Community Call
October 24, 2016
Pathomics Based Biomarkers, Tools, and Methods
Multi-scale Integrative Analysis in Biomedical Informatics
• Predict treatment
outcome, select,
monitor treatments
• Reduce inter-observer
variability in diagnosis
• Computer assisted
exploration of new
classification schemes
• Multi-scale cancer
simulations
Pathomics, Radiomics
Identify and segment trillions of objects – nuclei, glands,
ducts, nodules, tumor niches … from Pathology,
Radiology imaging datasets
Extract features from objects and spatio-temporal
regions
Support queries against ensembles of features extracted
from multiple datasets
Statistical analyses and machine learning to link
Radiology/Pathology features to “omics” and outcome
biological phenomena
Principle based analyses to bridge spatio-temporal scales
– linked Pathology, Radiology studies
Radiomics
Decoding tumour phenotype
by noninvasive imaging using
a quantitative radiomics
approach
Hugo J. W. L. Aerts et. Al.
Nature Communications 5, Article
number: 4006
doi:10.1038/ncomms5006
Features
Patients
Integrative
Morphology/”omics”
Quantitative Feature Analysis
in Pathology: Emory In Silico
Center for Brain Tumor
Research (PI = Dan Brat,
PD= Joel Saltz)
NLM/NCI: Integrative
Analysis/Digital Pathology
R01LM011119, R01LM009239
(Dual PIs Joel Saltz, David
Foran)
J Am Med Inform Assoc. 2012
Integrated morphologic
analysis for the
identification and
characterization of disease
subtypes.
Pathomics
Lee Cooper, Jun Kong
Tools to Analyze Morphology and Spatially Mapped
Molecular Data - U24 CA180924
• Specific Aim 1 Analysis pipelines for multi- scale,
integrative image analysis.
• Specific Aim 2: Database infrastructure to manage
and query Pathomics features.
• Specific Aim 3: HPC software that targets clusters,
cloud computing, and leadership scale systems.
• Specific Aim 4: Develop visualization middleware
to relate Pathomics feature and image data and to
integrate Pathomics image and “omic” data.
SEER Virtual Tissue Repository
• Lynne Penberthy MD, MPH NCI SEER
• Ed Helton PhD NCI CBIIT Clinical Imaging Program
• Ulrike Wagner CBIIT Clinical Imaging Program
• Radim Moravec NCI PhD, NCI SEER
• Ashish Sharma PhD Biomedical Informatics Emory
• Joel Saltz MD, PhD Biomedical Informatics Stony Brook
• Tahsin Kurc PhD Biomedical Informatics Stony Brook
Vision – Enable population/epidemiological cancer
research that leverages rich cancer phenotype
information available from Pathology tissue studies
NCIP/Leidos 14X138 and HHSN261200800001E - NCI
SEER Virtual Tissue Repository
• SEER registries are a potential source of
information about unusual outcomes and rare
cancers
• Leverage Pathology labs which store FFPE tumors,
slides and digital images
• Link to SEER data – track long term outcomes
• Accrue linked clinical data, Pathology slides from
SEER sites
SEER VIRTUAL TISSUE REPOSITORY
• Create linked collection of de-identified clinical data
and whole slide images
• Extract features from a sample set of images
(pancreas and breast cancer).
• Enable search, analysis, epidemiological
characterization
• Pilot focus on extreme outcome Breast Cancer,
Pancreatic Cancer cases
• Display images and analyzed features
Robust Nuclear Segmentation
• Robust ensemble algorithm to segment nuclei across tissue types
• Optimized algorithm tuning methods
• Parameter exploration to optimize quality
• Systematic Quality Control pipeline encompassing tissue image
quality, human generated ground truth, convolutional neural
network critique
• Yi Gao, Allen Tannenbaum, Dimitris Samaras, Le Hou, Tahsin Kurc
Cell Morphometry Features
Pathomics Based Biomarkers, Tools, and Methods
Feature Explorer Suite
• Explore Relationship Between Imaging Features,
Outcome, ”omics”
• Explore relationships between features and explore
how features relate to images
Feature Explorer - Integrated Pathomics Features, Outcomes
and “omics” – TCGA NSCLC Adeno Carcinoma Patients
Feature Explorer - Integrated Pathomics Features, Outcomes
and “omics” – TCGA NSCLC Adeno Carcinoma Patients
Collaboration with MGH – Feature Explorer – Radiology Brain
MR/Pathology Features
Collaboration with SBU Radiology – TCGA NSCLC Adeno Carcinoma
Integrative Radiology, Pathology, “omics”, outcome
Mary Saltz, Mark Schweitzer SBU Radiology
Pathomics
Relationship Between Image and FeaturesLeveraging Visualization to Aid in Feature Management
Step 1: Choose a case from the TCGA atlas (case #20)
Step 2: Select two features of interest; X
axis (area), Y axis (perimeter)
Step 3: Zoom in on region of interest
Step 4: Pick a specific nucleus of interest.
Each dot represents a single nucleus
Step 5: Evaluate the features selected in the context of
the specific nucleus and where this nucleus is located
within the whole slide image
The tool provides visual context for feature evaluation. This technique maps both intuitive features (i.e.
size, shape, color) and non-intuitive features (i.e. wavelets, texture) to the ground truth of source
images through an interactive web-based user interface.
Selected nucleus
geolocated within
whole slide image
Detects
elongated
nucleus
Going from the whole slide data set to selected features and back to the image
Adding a visual perspective by using a live web-based interactive tool (http://sbu-bmi.github.io/featurescape/u24/Preview.html)
Pathomics Based Biomarkers, Tools, and Methods
Select Feature Pair – dots correspond to nuclei
Subregion selected – form of gating analogous to flow
cytometry
Sample Nuclei from Gated Region
Gated Nuclei in Context
Algorithm Comparison, Validation, Uncertainty Quantification
• High quality image analysis algorithms are essential to
support biomedical research and diagnosis
• Validate algorithms with human annotations
• Compare and consolidate different algorithm results
e.g.: what are the distances and overlap ratios between
markup boundaries from two algorithms?
Green: algorithm 1
Red: algorithm 2
Cross matching of two
spatial data sets
MICCAI 2014
Brain Tumor
Introduction
caMicroscope/MongoDB - Multiple Algorithm Comparison;
Generate and Curate Pathomics Feature set
Compare Algorithm Results
Heatmap – Depicts Agreement Between Algorithms
3D Slicer Pathology – Generate High Quality
Ground Truth
Apply Segmentation Algorithm
Adjust algorithm parameters, manual fine tuning
Auto-tuning and feature extraction
• Goal – correctly segment trillions of objects (nuclei)
• Adjust algorithm parameters
• Autotuning – finds parameters that best match ground
truth in an image patch
• Region template runtime support to optimize
generation and management of multi-parameter
algorithm results
• Eliminates redundant computation, manages locality
• Active Harmony – Jeff Hollingsworth!!
• Collaboration – George Teodoro, Tahsin Kurc
Pathomics Based Biomarkers, Tools, and Methods
E=Eliminate Duplicate Compuations
Performance Optimization
256 nodes of Stampede. Each node of the cluster has a dual socket Intel Xeon
E5-2680 processors, an Intel Xeon Phi SE10P co-processor and 32GB RAM.The
nodes are inter-connected via Mellanox FDR Infiniband switches.
Classification
• Automated or semi-automated identification of
tissue or cell type
• Variety of machine learning and deep learning
methods
• Classification of Neuroblastoma
• Classification of Gliomas
• Quantification of lymphocyte infiltration
Classification and Characterization of Heterogeneity
Gurcan, Shamada, Kong, Saltz
Hiro Shimada, Metin Gurcan, Jun Kong, Lee Cooper Joel Saltz
BISTI/NIBIB Center for Grid Enabled Image Analysis - P20 EB000591, PI Saltz
lassification and Characterization of
Heterogeneity
Neuroblastoma Classification
FH: favorable histology UH: unfavorable histology
CANCER 2003; 98:2274-81
<5 yr
Schwannian
Development
≥50%
Grossly visible Nodule(s)
absent
present
Microscopic
Neuroblastic
foci
absent
present
Ganglioneuroma
(Schwannian stroma-dominant)
Maturing subtype
Mature subtype
Ganglioneuroblastoma, Intermixed
(Schwannian stroma-rich)
FH
FH
Ganglioneuroblastoma, Nodular
(composite, Schwannian stroma-rich/
stroma-dominant and stroma-poor) UH/FH*
Variant forms*
None to <50%
Neuroblastoma
(Schwannian stroma-poor)
Poorly differentiated
subtype
Undifferentiated
subtype
Differentiating
subtype
Any age UH
≥200/5,000 cells
Mitotic & karyorrhectic cells
100-200/5,000 cells
<100/5,000 cells
Any age
≥1.5 yr
<1.5 yr
UH
UH
FH
≥200/5,000 cells
100-200/5,000 cells
<100/5,000 cells
Any age UH
≥1.5 yr
<1.5 yr
≥5 yr
UH
FH
UH
FH
Multi-Scale Machine Learning Based Shimada Classification System
• Background Identification
• Image Decomposition (Multi-resolution
levels)
• Image Segmentation (EMLDA)
• Feature Construction (2nd order statistics,
Tonal Features)
• Feature Extraction (LDA) + Classification
(Bayesian)
• Multi-resolution Layer Controller
(Confidence Region)
No
Yes
Image Tile
Initialization
I = L
Background? Label
Create Image I(L)
Segmentation
Feature Construction
Feature Extraction
Classification
Segmentation
Feature Construction
Feature Extraction
Classifier Training
Down-sampling
Training Tiles
Within Confidence
Region ?
I = I -1
I > 1?
Yes
Yes
No
No
TRAINING
TESTING
Pathomics Based Biomarkers, Tools, and Methods
Brain Tumor Classification – CVPR 2016
Combining Information from Patches
Brain Tumor Classification Results
Le Hou, Dimitris Samaras, Tahsin Kurc, Yi Gao, Liz Vanner, James
Davis, Joel Saltz
Tumor Infiltrating Lymphocyte quantification
• Convolutional neural
network to classify
lymphocyte
infiltration in tissue
patches
• Convolutional neural
network and random
forest to classify
individual
segmented nuclei
• Extensive collection
of ground truth
• Joint work with
Emory and TCGA
PanCanAtlas
Immune group
Unsupervised Autoencoder – 100 feature dimensions
Lymphocyte identification
Lymphocytes Infiltration No Lymphocyte
Infiltration
Receiver Operating Characteristic – Area Under Curve – 95%
Lymphocyte Classification Heat Map
Trained with 22.2K image patches
Pathologist corrects and edits
Good Bad
Test as Good 2916 33
Test as Bad 28 2094
Machine Learning and Quality Critiquing
Dissemination
• Containers
• Cloud
• TCIA
• HPC via NSF and DOE
• TCGA – PanCanAtlas – Lymphocyte characterization
• Integrated Features/NLP joint with TIES
ITCR Team
Stony Brook University
Joel Saltz
Tahsin Kurc
Yi Gao
Allen Tannenbaum
Erich Bremer
Jonas Almeida
Alina Jasniewski
Fusheng Wang
Tammy DiPrima
Andrew White
Le Hou
Furqan Baig
Mary Saltz
Emory University
Ashish Sharma
Adam Marcus
Oak Ridge National Laboratory
Scott Klasky
Dave Pugmire
Jeremy Logan
Yale University
Michael Krauthammer
Harvard University
Rick Cummings
Funding – Thanks!
• This work was supported in part by U24CA180924-
01, NCIP/Leidos 14X138 and HHSN261200800001E
from the NCI; R01LM011119-01 and R01LM009239
from the NLM
• This research used resources provided by the
National Science Foundation XSEDE Science
Gateways program under grant TG-ASC130023 and
the Keeneland Computing Facility at the Georgia
Institute of Technology, which is supported by the
NSF under Contract OCI-0910735.
Thanks!
Ad

More Related Content

What's hot (20)

Artificial Intelligence in pathology
Artificial Intelligence in pathologyArtificial Intelligence in pathology
Artificial Intelligence in pathology
nehaSingh1543
 
TCIA
TCIATCIA
TCIA
Nigel Parsad
 
University of Toronto - Radiomics for Oncology - 2017
University of Toronto  - Radiomics for Oncology - 2017University of Toronto  - Radiomics for Oncology - 2017
University of Toronto - Radiomics for Oncology - 2017
Andre Dekker
 
Ph.D. Defense Presentation Slides (Changhee Han) カリスの東大博論審査会(公聴会)発表スライド Patho...
Ph.D. Defense Presentation Slides (Changhee Han) カリスの東大博論審査会(公聴会)発表スライド Patho...Ph.D. Defense Presentation Slides (Changhee Han) カリスの東大博論審査会(公聴会)発表スライド Patho...
Ph.D. Defense Presentation Slides (Changhee Han) カリスの東大博論審査会(公聴会)発表スライド Patho...
カリス 東大AI博士
 
Digital Pathology: Precision Medicine, Deep Learning and Computer Aided Inter...
Digital Pathology: Precision Medicine, Deep Learning and Computer Aided Inter...Digital Pathology: Precision Medicine, Deep Learning and Computer Aided Inter...
Digital Pathology: Precision Medicine, Deep Learning and Computer Aided Inter...
Joel Saltz
 
E-book Thesis Sara Carvalho
E-book Thesis  Sara CarvalhoE-book Thesis  Sara Carvalho
E-book Thesis Sara Carvalho
Sara Carvalho
 
Digital pathology in developing country
Digital pathology in developing countryDigital pathology in developing country
Digital pathology in developing country
Dr. Ashish lakhey
 
Dekker trog - knowledge engineering in radiation oncology - 2017
Dekker   trog  - knowledge engineering in radiation oncology - 2017Dekker   trog  - knowledge engineering in radiation oncology - 2017
Dekker trog - knowledge engineering in radiation oncology - 2017
Andre Dekker
 
Dekker trog - radiomics for oncology - 2017
Dekker   trog  - radiomics for oncology - 2017Dekker   trog  - radiomics for oncology - 2017
Dekker trog - radiomics for oncology - 2017
Andre Dekker
 
Public Databases for Radiomics Research: Current Status and Future Directions
Public Databases for Radiomics Research: Current Status and Future DirectionsPublic Databases for Radiomics Research: Current Status and Future Directions
Public Databases for Radiomics Research: Current Status and Future Directions
CancerImagingInforma
 
Learning, Training,  Classification,  Common Sense and Exascale Computing
Learning, Training,  Classification,  Common Sense and Exascale ComputingLearning, Training,  Classification,  Common Sense and Exascale Computing
Learning, Training,  Classification,  Common Sense and Exascale Computing
Joel Saltz
 
Definiens In Digital Pathology Hr
Definiens In Digital Pathology HrDefiniens In Digital Pathology Hr
Definiens In Digital Pathology Hr
Daniel Nicolson
 
Extreme Computing, Clinical Medicine and GPUs or Can GPUs Cure Cancer
Extreme Computing, Clinical Medicine and GPUs or Can GPUs Cure CancerExtreme Computing, Clinical Medicine and GPUs or Can GPUs Cure Cancer
Extreme Computing, Clinical Medicine and GPUs or Can GPUs Cure Cancer
Joel Saltz
 
Big Databases and Outcome Research - Opportunities and Challenges for Radiati...
Big Databases and Outcome Research - Opportunities and Challenges for Radiati...Big Databases and Outcome Research - Opportunities and Challenges for Radiati...
Big Databases and Outcome Research - Opportunities and Challenges for Radiati...
Andre Dekker
 
Dekker trog - big data for radiation oncology - 2017
Dekker   trog  - big data for radiation oncology - 2017Dekker   trog  - big data for radiation oncology - 2017
Dekker trog - big data for radiation oncology - 2017
Andre Dekker
 
Presentation clinical applications of Artificial Intelligence for radiation o...
Presentation clinical applications of Artificial Intelligence for radiation o...Presentation clinical applications of Artificial Intelligence for radiation o...
Presentation clinical applications of Artificial Intelligence for radiation o...
Jean-Emmanuel Bibault Bibault, MD, PhD
 
Data Mining Techniques In Computer Aided Cancer Diagnosis
Data Mining Techniques In Computer Aided Cancer DiagnosisData Mining Techniques In Computer Aided Cancer Diagnosis
Data Mining Techniques In Computer Aided Cancer Diagnosis
DataminingTools Inc
 
Digital Pathology at John Hopkins
Digital Pathology at John HopkinsDigital Pathology at John Hopkins
Digital Pathology at John Hopkins
William Baird
 
Computational Pathology Workshop July 8 2014
Computational Pathology Workshop July 8 2014Computational Pathology Workshop July 8 2014
Computational Pathology Workshop July 8 2014
Joel Saltz
 
Radiomics Data Management, Computation, and Analysis for QIN F2F 2016
Radiomics Data Management, Computation, and Analysis for QIN F2F 2016Radiomics Data Management, Computation, and Analysis for QIN F2F 2016
Radiomics Data Management, Computation, and Analysis for QIN F2F 2016
Ashish Sharma
 
Artificial Intelligence in pathology
Artificial Intelligence in pathologyArtificial Intelligence in pathology
Artificial Intelligence in pathology
nehaSingh1543
 
University of Toronto - Radiomics for Oncology - 2017
University of Toronto  - Radiomics for Oncology - 2017University of Toronto  - Radiomics for Oncology - 2017
University of Toronto - Radiomics for Oncology - 2017
Andre Dekker
 
Ph.D. Defense Presentation Slides (Changhee Han) カリスの東大博論審査会(公聴会)発表スライド Patho...
Ph.D. Defense Presentation Slides (Changhee Han) カリスの東大博論審査会(公聴会)発表スライド Patho...Ph.D. Defense Presentation Slides (Changhee Han) カリスの東大博論審査会(公聴会)発表スライド Patho...
Ph.D. Defense Presentation Slides (Changhee Han) カリスの東大博論審査会(公聴会)発表スライド Patho...
カリス 東大AI博士
 
Digital Pathology: Precision Medicine, Deep Learning and Computer Aided Inter...
Digital Pathology: Precision Medicine, Deep Learning and Computer Aided Inter...Digital Pathology: Precision Medicine, Deep Learning and Computer Aided Inter...
Digital Pathology: Precision Medicine, Deep Learning and Computer Aided Inter...
Joel Saltz
 
E-book Thesis Sara Carvalho
E-book Thesis  Sara CarvalhoE-book Thesis  Sara Carvalho
E-book Thesis Sara Carvalho
Sara Carvalho
 
Digital pathology in developing country
Digital pathology in developing countryDigital pathology in developing country
Digital pathology in developing country
Dr. Ashish lakhey
 
Dekker trog - knowledge engineering in radiation oncology - 2017
Dekker   trog  - knowledge engineering in radiation oncology - 2017Dekker   trog  - knowledge engineering in radiation oncology - 2017
Dekker trog - knowledge engineering in radiation oncology - 2017
Andre Dekker
 
Dekker trog - radiomics for oncology - 2017
Dekker   trog  - radiomics for oncology - 2017Dekker   trog  - radiomics for oncology - 2017
Dekker trog - radiomics for oncology - 2017
Andre Dekker
 
Public Databases for Radiomics Research: Current Status and Future Directions
Public Databases for Radiomics Research: Current Status and Future DirectionsPublic Databases for Radiomics Research: Current Status and Future Directions
Public Databases for Radiomics Research: Current Status and Future Directions
CancerImagingInforma
 
Learning, Training,  Classification,  Common Sense and Exascale Computing
Learning, Training,  Classification,  Common Sense and Exascale ComputingLearning, Training,  Classification,  Common Sense and Exascale Computing
Learning, Training,  Classification,  Common Sense and Exascale Computing
Joel Saltz
 
Definiens In Digital Pathology Hr
Definiens In Digital Pathology HrDefiniens In Digital Pathology Hr
Definiens In Digital Pathology Hr
Daniel Nicolson
 
Extreme Computing, Clinical Medicine and GPUs or Can GPUs Cure Cancer
Extreme Computing, Clinical Medicine and GPUs or Can GPUs Cure CancerExtreme Computing, Clinical Medicine and GPUs or Can GPUs Cure Cancer
Extreme Computing, Clinical Medicine and GPUs or Can GPUs Cure Cancer
Joel Saltz
 
Big Databases and Outcome Research - Opportunities and Challenges for Radiati...
Big Databases and Outcome Research - Opportunities and Challenges for Radiati...Big Databases and Outcome Research - Opportunities and Challenges for Radiati...
Big Databases and Outcome Research - Opportunities and Challenges for Radiati...
Andre Dekker
 
Dekker trog - big data for radiation oncology - 2017
Dekker   trog  - big data for radiation oncology - 2017Dekker   trog  - big data for radiation oncology - 2017
Dekker trog - big data for radiation oncology - 2017
Andre Dekker
 
Presentation clinical applications of Artificial Intelligence for radiation o...
Presentation clinical applications of Artificial Intelligence for radiation o...Presentation clinical applications of Artificial Intelligence for radiation o...
Presentation clinical applications of Artificial Intelligence for radiation o...
Jean-Emmanuel Bibault Bibault, MD, PhD
 
Data Mining Techniques In Computer Aided Cancer Diagnosis
Data Mining Techniques In Computer Aided Cancer DiagnosisData Mining Techniques In Computer Aided Cancer Diagnosis
Data Mining Techniques In Computer Aided Cancer Diagnosis
DataminingTools Inc
 
Digital Pathology at John Hopkins
Digital Pathology at John HopkinsDigital Pathology at John Hopkins
Digital Pathology at John Hopkins
William Baird
 
Computational Pathology Workshop July 8 2014
Computational Pathology Workshop July 8 2014Computational Pathology Workshop July 8 2014
Computational Pathology Workshop July 8 2014
Joel Saltz
 
Radiomics Data Management, Computation, and Analysis for QIN F2F 2016
Radiomics Data Management, Computation, and Analysis for QIN F2F 2016Radiomics Data Management, Computation, and Analysis for QIN F2F 2016
Radiomics Data Management, Computation, and Analysis for QIN F2F 2016
Ashish Sharma
 

Similar to Pathomics Based Biomarkers, Tools, and Methods (20)

Digital Pathology, FDA Approval and Precision Medicine
Digital Pathology, FDA Approval and Precision MedicineDigital Pathology, FDA Approval and Precision Medicine
Digital Pathology, FDA Approval and Precision Medicine
Joel Saltz
 
Pathomics, Clinical Studies, and Cancer Surveillance
Pathomics, Clinical Studies, and Cancer SurveillancePathomics, Clinical Studies, and Cancer Surveillance
Pathomics, Clinical Studies, and Cancer Surveillance
Joel Saltz
 
Twenty Years of Whole Slide Imaging - the Coming Phase Change
Twenty Years of Whole Slide Imaging - the Coming Phase ChangeTwenty Years of Whole Slide Imaging - the Coming Phase Change
Twenty Years of Whole Slide Imaging - the Coming Phase Change
Joel Saltz
 
Generation and Use of Quantitative Pathology Phenotype
Generation and Use of Quantitative Pathology PhenotypeGeneration and Use of Quantitative Pathology Phenotype
Generation and Use of Quantitative Pathology Phenotype
Joel Saltz
 
Integrative Everything, Deep Learning and Streaming Data
Integrative Everything, Deep Learning and Streaming DataIntegrative Everything, Deep Learning and Streaming Data
Integrative Everything, Deep Learning and Streaming Data
Joel Saltz
 
AI and whole slide imaging biomarkers
AI and whole slide imaging biomarkersAI and whole slide imaging biomarkers
AI and whole slide imaging biomarkers
Joel Saltz
 
Artificial Intelligence in Radiation Oncology
Artificial Intelligence in Radiation OncologyArtificial Intelligence in Radiation Oncology
Artificial Intelligence in Radiation Oncology
Wookjin Choi
 
morphometry.pptx
morphometry.pptxmorphometry.pptx
morphometry.pptx
SarithaRani4
 
AI in Gynaec Onco
AI in Gynaec OncoAI in Gynaec Onco
AI in Gynaec Onco
Niranjan Chavan
 
seminar on new technologies of cell and molecular biology
seminar on new technologies of cell and molecular biologyseminar on new technologies of cell and molecular biology
seminar on new technologies of cell and molecular biology
Biswajit Deka
 
USP.ppt
USP.pptUSP.ppt
USP.ppt
Bkannan2
 
Challenges and opportunities for machine learning in biomedical research
Challenges and opportunities for machine learning in biomedical researchChallenges and opportunities for machine learning in biomedical research
Challenges and opportunities for machine learning in biomedical research
FranciscoJAzuajeG
 
Iaetsd classification of lung tumour using
Iaetsd classification of lung tumour usingIaetsd classification of lung tumour using
Iaetsd classification of lung tumour using
Iaetsd Iaetsd
 
Women in STEM
Women in STEM Women in STEM
Women in STEM
Kritika Lakhotia
 
[DSC Europe 23][DigiHealth] Tomislav Krizan - AIMED
[DSC Europe 23][DigiHealth] Tomislav Krizan - AIMED[DSC Europe 23][DigiHealth] Tomislav Krizan - AIMED
[DSC Europe 23][DigiHealth] Tomislav Krizan - AIMED
DataScienceConferenc1
 
Cancer tissue evaluation.pptx
Cancer tissue evaluation.pptxCancer tissue evaluation.pptx
Cancer tissue evaluation.pptx
KerenEvangelineI
 
ICBO 2014, October 8, 2014
ICBO 2014, October 8, 2014ICBO 2014, October 8, 2014
ICBO 2014, October 8, 2014
Warren Kibbe
 
Second Review Research in quantifying lymphocytes.pptx
Second Review Research in quantifying lymphocytes.pptxSecond Review Research in quantifying lymphocytes.pptx
Second Review Research in quantifying lymphocytes.pptx
KerenEvangelineI
 
Tools to Analyze Morphology and Spatially Mapped Molecular Data - Informatio...
Tools to Analyze Morphology and Spatially Mapped Molecular Data -  Informatio...Tools to Analyze Morphology and Spatially Mapped Molecular Data -  Informatio...
Tools to Analyze Morphology and Spatially Mapped Molecular Data - Informatio...
Joel Saltz
 
Machine Learning in Biology and Why It Doesn't Make Sense - Theo Knijnenburg,...
Machine Learning in Biology and Why It Doesn't Make Sense - Theo Knijnenburg,...Machine Learning in Biology and Why It Doesn't Make Sense - Theo Knijnenburg,...
Machine Learning in Biology and Why It Doesn't Make Sense - Theo Knijnenburg,...
Seattle DAML meetup
 
Digital Pathology, FDA Approval and Precision Medicine
Digital Pathology, FDA Approval and Precision MedicineDigital Pathology, FDA Approval and Precision Medicine
Digital Pathology, FDA Approval and Precision Medicine
Joel Saltz
 
Pathomics, Clinical Studies, and Cancer Surveillance
Pathomics, Clinical Studies, and Cancer SurveillancePathomics, Clinical Studies, and Cancer Surveillance
Pathomics, Clinical Studies, and Cancer Surveillance
Joel Saltz
 
Twenty Years of Whole Slide Imaging - the Coming Phase Change
Twenty Years of Whole Slide Imaging - the Coming Phase ChangeTwenty Years of Whole Slide Imaging - the Coming Phase Change
Twenty Years of Whole Slide Imaging - the Coming Phase Change
Joel Saltz
 
Generation and Use of Quantitative Pathology Phenotype
Generation and Use of Quantitative Pathology PhenotypeGeneration and Use of Quantitative Pathology Phenotype
Generation and Use of Quantitative Pathology Phenotype
Joel Saltz
 
Integrative Everything, Deep Learning and Streaming Data
Integrative Everything, Deep Learning and Streaming DataIntegrative Everything, Deep Learning and Streaming Data
Integrative Everything, Deep Learning and Streaming Data
Joel Saltz
 
AI and whole slide imaging biomarkers
AI and whole slide imaging biomarkersAI and whole slide imaging biomarkers
AI and whole slide imaging biomarkers
Joel Saltz
 
Artificial Intelligence in Radiation Oncology
Artificial Intelligence in Radiation OncologyArtificial Intelligence in Radiation Oncology
Artificial Intelligence in Radiation Oncology
Wookjin Choi
 
seminar on new technologies of cell and molecular biology
seminar on new technologies of cell and molecular biologyseminar on new technologies of cell and molecular biology
seminar on new technologies of cell and molecular biology
Biswajit Deka
 
Challenges and opportunities for machine learning in biomedical research
Challenges and opportunities for machine learning in biomedical researchChallenges and opportunities for machine learning in biomedical research
Challenges and opportunities for machine learning in biomedical research
FranciscoJAzuajeG
 
Iaetsd classification of lung tumour using
Iaetsd classification of lung tumour usingIaetsd classification of lung tumour using
Iaetsd classification of lung tumour using
Iaetsd Iaetsd
 
[DSC Europe 23][DigiHealth] Tomislav Krizan - AIMED
[DSC Europe 23][DigiHealth] Tomislav Krizan - AIMED[DSC Europe 23][DigiHealth] Tomislav Krizan - AIMED
[DSC Europe 23][DigiHealth] Tomislav Krizan - AIMED
DataScienceConferenc1
 
Cancer tissue evaluation.pptx
Cancer tissue evaluation.pptxCancer tissue evaluation.pptx
Cancer tissue evaluation.pptx
KerenEvangelineI
 
ICBO 2014, October 8, 2014
ICBO 2014, October 8, 2014ICBO 2014, October 8, 2014
ICBO 2014, October 8, 2014
Warren Kibbe
 
Second Review Research in quantifying lymphocytes.pptx
Second Review Research in quantifying lymphocytes.pptxSecond Review Research in quantifying lymphocytes.pptx
Second Review Research in quantifying lymphocytes.pptx
KerenEvangelineI
 
Tools to Analyze Morphology and Spatially Mapped Molecular Data - Informatio...
Tools to Analyze Morphology and Spatially Mapped Molecular Data -  Informatio...Tools to Analyze Morphology and Spatially Mapped Molecular Data -  Informatio...
Tools to Analyze Morphology and Spatially Mapped Molecular Data - Informatio...
Joel Saltz
 
Machine Learning in Biology and Why It Doesn't Make Sense - Theo Knijnenburg,...
Machine Learning in Biology and Why It Doesn't Make Sense - Theo Knijnenburg,...Machine Learning in Biology and Why It Doesn't Make Sense - Theo Knijnenburg,...
Machine Learning in Biology and Why It Doesn't Make Sense - Theo Knijnenburg,...
Seattle DAML meetup
 
Ad

More from imgcommcall (20)

Making Radiology AI Models more robust: Federated Learning and other Approaches
Making Radiology AI Models more robust: Federated Learning and other ApproachesMaking Radiology AI Models more robust: Federated Learning and other Approaches
Making Radiology AI Models more robust: Federated Learning and other Approaches
imgcommcall
 
Agenda NCI Imaging Informatics Webinar 2020-07-06
Agenda NCI Imaging Informatics Webinar 2020-07-06Agenda NCI Imaging Informatics Webinar 2020-07-06
Agenda NCI Imaging Informatics Webinar 2020-07-06
imgcommcall
 
AI-LAB
AI-LABAI-LAB
AI-LAB
imgcommcall
 
PathPresenter
PathPresenterPathPresenter
PathPresenter
imgcommcall
 
Agenda April 6, 2020
Agenda April 6, 2020Agenda April 6, 2020
Agenda April 6, 2020
imgcommcall
 
Medical Segmentation Decathalon
Medical Segmentation DecathalonMedical Segmentation Decathalon
Medical Segmentation Decathalon
imgcommcall
 
Agenda - NCI Imaging Community Call
Agenda - NCI Imaging Community CallAgenda - NCI Imaging Community Call
Agenda - NCI Imaging Community Call
imgcommcall
 
NCI Cancer Research Data Commons - Overview
NCI Cancer Research Data Commons - OverviewNCI Cancer Research Data Commons - Overview
NCI Cancer Research Data Commons - Overview
imgcommcall
 
Imaging Data Commons (IDC) - Introduction and intital approach
Imaging Data Commons (IDC) - Introduction and intital approachImaging Data Commons (IDC) - Introduction and intital approach
Imaging Data Commons (IDC) - Introduction and intital approach
imgcommcall
 
NCI Imaging community call agenda
NCI Imaging community call agendaNCI Imaging community call agenda
NCI Imaging community call agenda
imgcommcall
 
CPTAC Data at the Genomic Data Commons
CPTAC Data at the Genomic Data CommonsCPTAC Data at the Genomic Data Commons
CPTAC Data at the Genomic Data Commons
imgcommcall
 
CPTAC Data Portal and Proteomics Data Commons
CPTAC Data Portal and Proteomics Data CommonsCPTAC Data Portal and Proteomics Data Commons
CPTAC Data Portal and Proteomics Data Commons
imgcommcall
 
Clinical Proteomic Tumor Analysis Consortium (CPTAC) Overview
Clinical Proteomic Tumor Analysis Consortium (CPTAC) OverviewClinical Proteomic Tumor Analysis Consortium (CPTAC) Overview
Clinical Proteomic Tumor Analysis Consortium (CPTAC) Overview
imgcommcall
 
PRISM Semantic Integration Approach
PRISM Semantic Integration ApproachPRISM Semantic Integration Approach
PRISM Semantic Integration Approach
imgcommcall
 
PRISM Project Update
PRISM Project UpdatePRISM Project Update
PRISM Project Update
imgcommcall
 
TCIA Update
TCIA UpdateTCIA Update
TCIA Update
imgcommcall
 
Image community 2019 06-03
Image community 2019 06-03Image community 2019 06-03
Image community 2019 06-03
imgcommcall
 
NBIA 7.0 Community Version Release
NBIA 7.0 Community Version ReleaseNBIA 7.0 Community Version Release
NBIA 7.0 Community Version Release
imgcommcall
 
Image community 2019 05-06
Image community 2019 05-06Image community 2019 05-06
Image community 2019 05-06
imgcommcall
 
Image community 2019 03-04
Image community 2019 03-04Image community 2019 03-04
Image community 2019 03-04
imgcommcall
 
Making Radiology AI Models more robust: Federated Learning and other Approaches
Making Radiology AI Models more robust: Federated Learning and other ApproachesMaking Radiology AI Models more robust: Federated Learning and other Approaches
Making Radiology AI Models more robust: Federated Learning and other Approaches
imgcommcall
 
Agenda NCI Imaging Informatics Webinar 2020-07-06
Agenda NCI Imaging Informatics Webinar 2020-07-06Agenda NCI Imaging Informatics Webinar 2020-07-06
Agenda NCI Imaging Informatics Webinar 2020-07-06
imgcommcall
 
Agenda April 6, 2020
Agenda April 6, 2020Agenda April 6, 2020
Agenda April 6, 2020
imgcommcall
 
Medical Segmentation Decathalon
Medical Segmentation DecathalonMedical Segmentation Decathalon
Medical Segmentation Decathalon
imgcommcall
 
Agenda - NCI Imaging Community Call
Agenda - NCI Imaging Community CallAgenda - NCI Imaging Community Call
Agenda - NCI Imaging Community Call
imgcommcall
 
NCI Cancer Research Data Commons - Overview
NCI Cancer Research Data Commons - OverviewNCI Cancer Research Data Commons - Overview
NCI Cancer Research Data Commons - Overview
imgcommcall
 
Imaging Data Commons (IDC) - Introduction and intital approach
Imaging Data Commons (IDC) - Introduction and intital approachImaging Data Commons (IDC) - Introduction and intital approach
Imaging Data Commons (IDC) - Introduction and intital approach
imgcommcall
 
NCI Imaging community call agenda
NCI Imaging community call agendaNCI Imaging community call agenda
NCI Imaging community call agenda
imgcommcall
 
CPTAC Data at the Genomic Data Commons
CPTAC Data at the Genomic Data CommonsCPTAC Data at the Genomic Data Commons
CPTAC Data at the Genomic Data Commons
imgcommcall
 
CPTAC Data Portal and Proteomics Data Commons
CPTAC Data Portal and Proteomics Data CommonsCPTAC Data Portal and Proteomics Data Commons
CPTAC Data Portal and Proteomics Data Commons
imgcommcall
 
Clinical Proteomic Tumor Analysis Consortium (CPTAC) Overview
Clinical Proteomic Tumor Analysis Consortium (CPTAC) OverviewClinical Proteomic Tumor Analysis Consortium (CPTAC) Overview
Clinical Proteomic Tumor Analysis Consortium (CPTAC) Overview
imgcommcall
 
PRISM Semantic Integration Approach
PRISM Semantic Integration ApproachPRISM Semantic Integration Approach
PRISM Semantic Integration Approach
imgcommcall
 
PRISM Project Update
PRISM Project UpdatePRISM Project Update
PRISM Project Update
imgcommcall
 
Image community 2019 06-03
Image community 2019 06-03Image community 2019 06-03
Image community 2019 06-03
imgcommcall
 
NBIA 7.0 Community Version Release
NBIA 7.0 Community Version ReleaseNBIA 7.0 Community Version Release
NBIA 7.0 Community Version Release
imgcommcall
 
Image community 2019 05-06
Image community 2019 05-06Image community 2019 05-06
Image community 2019 05-06
imgcommcall
 
Image community 2019 03-04
Image community 2019 03-04Image community 2019 03-04
Image community 2019 03-04
imgcommcall
 
Ad

Recently uploaded (20)

Information Resources Adverse Drug Reaction.pptx
Information Resources Adverse Drug Reaction.pptxInformation Resources Adverse Drug Reaction.pptx
Information Resources Adverse Drug Reaction.pptx
Dr. Koppala R.V.S. Chaitanya
 
Meeting dissolution requirements M.Pharmacy sem 2nd biopharmaceutics &pharmac...
Meeting dissolution requirements M.Pharmacy sem 2nd biopharmaceutics &pharmac...Meeting dissolution requirements M.Pharmacy sem 2nd biopharmaceutics &pharmac...
Meeting dissolution requirements M.Pharmacy sem 2nd biopharmaceutics &pharmac...
Swami ramanand teerth marathwada university
 
Methods of Cancer diagnosis in Context of Radiotherapy
Methods of Cancer diagnosis in Context  of RadiotherapyMethods of Cancer diagnosis in Context  of Radiotherapy
Methods of Cancer diagnosis in Context of Radiotherapy
Saikat Roy
 
Physiology of Pain and thermal sensations
Physiology of Pain and thermal sensationsPhysiology of Pain and thermal sensations
Physiology of Pain and thermal sensations
MedicoseAcademics
 
SPECIFIC ETHICAL ISSUES, FFP, AUTHORSHIP,CONFLICT OF INTEREST.pptx
SPECIFIC ETHICAL ISSUES, FFP, AUTHORSHIP,CONFLICT OF INTEREST.pptxSPECIFIC ETHICAL ISSUES, FFP, AUTHORSHIP,CONFLICT OF INTEREST.pptx
SPECIFIC ETHICAL ISSUES, FFP, AUTHORSHIP,CONFLICT OF INTEREST.pptx
SanskritiUpadhyay5
 
Normal distribution and Z score Test for post graduate and undergraduate stu...
Normal distribution and Z score Test  for post graduate and undergraduate stu...Normal distribution and Z score Test  for post graduate and undergraduate stu...
Normal distribution and Z score Test for post graduate and undergraduate stu...
Tauseef Jawaid
 
Common Male Sexual Problems | Best Sexologist in Patna, Bihar | Dr. Sunil Dubey
Common Male Sexual Problems | Best Sexologist in Patna, Bihar | Dr. Sunil DubeyCommon Male Sexual Problems | Best Sexologist in Patna, Bihar | Dr. Sunil Dubey
Common Male Sexual Problems | Best Sexologist in Patna, Bihar | Dr. Sunil Dubey
Sexologist Dr. Sunil Dubey - Dubey Clinic
 
Esophageal Cancer: Artificial Intelligence, Synergetics, Complex System Analy...
Esophageal Cancer: Artificial Intelligence, Synergetics, Complex System Analy...Esophageal Cancer: Artificial Intelligence, Synergetics, Complex System Analy...
Esophageal Cancer: Artificial Intelligence, Synergetics, Complex System Analy...
Oleg Kshivets
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, B...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, B...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, B...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, B...
Oleg Kshivets
 
Introduction to the heart for pharm d I year.pptx
Introduction to the heart for pharm d I year.pptxIntroduction to the heart for pharm d I year.pptx
Introduction to the heart for pharm d I year.pptx
rekhapositivity
 
A comparative study of onlay versus sublay mesh repair in the surgical manage...
A comparative study of onlay versus sublay mesh repair in the surgical manage...A comparative study of onlay versus sublay mesh repair in the surgical manage...
A comparative study of onlay versus sublay mesh repair in the surgical manage...
Sona Thesis Consultancy
 
Role of Gene Therapy Neurological disorders
Role of Gene Therapy Neurological disordersRole of Gene Therapy Neurological disorders
Role of Gene Therapy Neurological disorders
riggdiana2
 
2025-ADA-SOC-Slide-Deck-all-recommendations-FINAL-12-9-24.pptx
2025-ADA-SOC-Slide-Deck-all-recommendations-FINAL-12-9-24.pptx2025-ADA-SOC-Slide-Deck-all-recommendations-FINAL-12-9-24.pptx
2025-ADA-SOC-Slide-Deck-all-recommendations-FINAL-12-9-24.pptx
Tanja Milenković
 
Severity and seriousness assessment: Pharmacovigilance aspects.
Severity and seriousness assessment: Pharmacovigilance aspects.Severity and seriousness assessment: Pharmacovigilance aspects.
Severity and seriousness assessment: Pharmacovigilance aspects.
Dr. Koppala R.V.S. Chaitanya
 
Physicochemical Nature of the Drug Formulation | Factors Affecting Drug Produ...
Physicochemical Nature of the Drug Formulation | Factors Affecting Drug Produ...Physicochemical Nature of the Drug Formulation | Factors Affecting Drug Produ...
Physicochemical Nature of the Drug Formulation | Factors Affecting Drug Produ...
Y Subhasish Singha
 
Introduction to adverse drug reactions & Management of ADR.pptx
Introduction to adverse drug reactions & Management of ADR.pptxIntroduction to adverse drug reactions & Management of ADR.pptx
Introduction to adverse drug reactions & Management of ADR.pptx
Dr. Koppala R.V.S. Chaitanya
 
Evaluation of cosmetic products-Dhanashree Kolhekar-M.PHARM.pptx
Evaluation of cosmetic products-Dhanashree Kolhekar-M.PHARM.pptxEvaluation of cosmetic products-Dhanashree Kolhekar-M.PHARM.pptx
Evaluation of cosmetic products-Dhanashree Kolhekar-M.PHARM.pptx
DR. BABASAHEB BHIMRAO AMBEDKAR (A CENTRAL GOVT.) UNIVERSITY, LUCKNOW, UP.
 
various methods and techniques used and Pharmacovigilance Methods.pptx
various methods and techniques used and Pharmacovigilance Methods.pptxvarious methods and techniques used and Pharmacovigilance Methods.pptx
various methods and techniques used and Pharmacovigilance Methods.pptx
Dr. Koppala R.V.S. Chaitanya
 
Lecture chi squire. For Postgraduate and Undergraduate
Lecture chi squire. For Postgraduate and UndergraduateLecture chi squire. For Postgraduate and Undergraduate
Lecture chi squire. For Postgraduate and Undergraduate
Tauseef Jawaid
 
Pharmacology All Notes 505 Slides (2).pptx
Pharmacology All Notes 505 Slides (2).pptxPharmacology All Notes 505 Slides (2).pptx
Pharmacology All Notes 505 Slides (2).pptx
ssuseraed25f1
 
Methods of Cancer diagnosis in Context of Radiotherapy
Methods of Cancer diagnosis in Context  of RadiotherapyMethods of Cancer diagnosis in Context  of Radiotherapy
Methods of Cancer diagnosis in Context of Radiotherapy
Saikat Roy
 
Physiology of Pain and thermal sensations
Physiology of Pain and thermal sensationsPhysiology of Pain and thermal sensations
Physiology of Pain and thermal sensations
MedicoseAcademics
 
SPECIFIC ETHICAL ISSUES, FFP, AUTHORSHIP,CONFLICT OF INTEREST.pptx
SPECIFIC ETHICAL ISSUES, FFP, AUTHORSHIP,CONFLICT OF INTEREST.pptxSPECIFIC ETHICAL ISSUES, FFP, AUTHORSHIP,CONFLICT OF INTEREST.pptx
SPECIFIC ETHICAL ISSUES, FFP, AUTHORSHIP,CONFLICT OF INTEREST.pptx
SanskritiUpadhyay5
 
Normal distribution and Z score Test for post graduate and undergraduate stu...
Normal distribution and Z score Test  for post graduate and undergraduate stu...Normal distribution and Z score Test  for post graduate and undergraduate stu...
Normal distribution and Z score Test for post graduate and undergraduate stu...
Tauseef Jawaid
 
Common Male Sexual Problems | Best Sexologist in Patna, Bihar | Dr. Sunil Dubey
Common Male Sexual Problems | Best Sexologist in Patna, Bihar | Dr. Sunil DubeyCommon Male Sexual Problems | Best Sexologist in Patna, Bihar | Dr. Sunil Dubey
Common Male Sexual Problems | Best Sexologist in Patna, Bihar | Dr. Sunil Dubey
Sexologist Dr. Sunil Dubey - Dubey Clinic
 
Esophageal Cancer: Artificial Intelligence, Synergetics, Complex System Analy...
Esophageal Cancer: Artificial Intelligence, Synergetics, Complex System Analy...Esophageal Cancer: Artificial Intelligence, Synergetics, Complex System Analy...
Esophageal Cancer: Artificial Intelligence, Synergetics, Complex System Analy...
Oleg Kshivets
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, B...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, B...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, B...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, B...
Oleg Kshivets
 
Introduction to the heart for pharm d I year.pptx
Introduction to the heart for pharm d I year.pptxIntroduction to the heart for pharm d I year.pptx
Introduction to the heart for pharm d I year.pptx
rekhapositivity
 
A comparative study of onlay versus sublay mesh repair in the surgical manage...
A comparative study of onlay versus sublay mesh repair in the surgical manage...A comparative study of onlay versus sublay mesh repair in the surgical manage...
A comparative study of onlay versus sublay mesh repair in the surgical manage...
Sona Thesis Consultancy
 
Role of Gene Therapy Neurological disorders
Role of Gene Therapy Neurological disordersRole of Gene Therapy Neurological disorders
Role of Gene Therapy Neurological disorders
riggdiana2
 
2025-ADA-SOC-Slide-Deck-all-recommendations-FINAL-12-9-24.pptx
2025-ADA-SOC-Slide-Deck-all-recommendations-FINAL-12-9-24.pptx2025-ADA-SOC-Slide-Deck-all-recommendations-FINAL-12-9-24.pptx
2025-ADA-SOC-Slide-Deck-all-recommendations-FINAL-12-9-24.pptx
Tanja Milenković
 
Severity and seriousness assessment: Pharmacovigilance aspects.
Severity and seriousness assessment: Pharmacovigilance aspects.Severity and seriousness assessment: Pharmacovigilance aspects.
Severity and seriousness assessment: Pharmacovigilance aspects.
Dr. Koppala R.V.S. Chaitanya
 
Physicochemical Nature of the Drug Formulation | Factors Affecting Drug Produ...
Physicochemical Nature of the Drug Formulation | Factors Affecting Drug Produ...Physicochemical Nature of the Drug Formulation | Factors Affecting Drug Produ...
Physicochemical Nature of the Drug Formulation | Factors Affecting Drug Produ...
Y Subhasish Singha
 
Introduction to adverse drug reactions & Management of ADR.pptx
Introduction to adverse drug reactions & Management of ADR.pptxIntroduction to adverse drug reactions & Management of ADR.pptx
Introduction to adverse drug reactions & Management of ADR.pptx
Dr. Koppala R.V.S. Chaitanya
 
various methods and techniques used and Pharmacovigilance Methods.pptx
various methods and techniques used and Pharmacovigilance Methods.pptxvarious methods and techniques used and Pharmacovigilance Methods.pptx
various methods and techniques used and Pharmacovigilance Methods.pptx
Dr. Koppala R.V.S. Chaitanya
 
Lecture chi squire. For Postgraduate and Undergraduate
Lecture chi squire. For Postgraduate and UndergraduateLecture chi squire. For Postgraduate and Undergraduate
Lecture chi squire. For Postgraduate and Undergraduate
Tauseef Jawaid
 
Pharmacology All Notes 505 Slides (2).pptx
Pharmacology All Notes 505 Slides (2).pptxPharmacology All Notes 505 Slides (2).pptx
Pharmacology All Notes 505 Slides (2).pptx
ssuseraed25f1
 

Pathomics Based Biomarkers, Tools, and Methods

  • 1. Pathomics Based Biomarkers, Tools and Methods Joel Saltz Department of Biomedical Informatics Stony Brook University Imaging Community Call October 24, 2016
  • 3. Multi-scale Integrative Analysis in Biomedical Informatics • Predict treatment outcome, select, monitor treatments • Reduce inter-observer variability in diagnosis • Computer assisted exploration of new classification schemes • Multi-scale cancer simulations
  • 4. Pathomics, Radiomics Identify and segment trillions of objects – nuclei, glands, ducts, nodules, tumor niches … from Pathology, Radiology imaging datasets Extract features from objects and spatio-temporal regions Support queries against ensembles of features extracted from multiple datasets Statistical analyses and machine learning to link Radiology/Pathology features to “omics” and outcome biological phenomena Principle based analyses to bridge spatio-temporal scales – linked Pathology, Radiology studies
  • 5. Radiomics Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach Hugo J. W. L. Aerts et. Al. Nature Communications 5, Article number: 4006 doi:10.1038/ncomms5006 Features Patients
  • 6. Integrative Morphology/”omics” Quantitative Feature Analysis in Pathology: Emory In Silico Center for Brain Tumor Research (PI = Dan Brat, PD= Joel Saltz) NLM/NCI: Integrative Analysis/Digital Pathology R01LM011119, R01LM009239 (Dual PIs Joel Saltz, David Foran) J Am Med Inform Assoc. 2012 Integrated morphologic analysis for the identification and characterization of disease subtypes. Pathomics Lee Cooper, Jun Kong
  • 7. Tools to Analyze Morphology and Spatially Mapped Molecular Data - U24 CA180924 • Specific Aim 1 Analysis pipelines for multi- scale, integrative image analysis. • Specific Aim 2: Database infrastructure to manage and query Pathomics features. • Specific Aim 3: HPC software that targets clusters, cloud computing, and leadership scale systems. • Specific Aim 4: Develop visualization middleware to relate Pathomics feature and image data and to integrate Pathomics image and “omic” data.
  • 8. SEER Virtual Tissue Repository • Lynne Penberthy MD, MPH NCI SEER • Ed Helton PhD NCI CBIIT Clinical Imaging Program • Ulrike Wagner CBIIT Clinical Imaging Program • Radim Moravec NCI PhD, NCI SEER • Ashish Sharma PhD Biomedical Informatics Emory • Joel Saltz MD, PhD Biomedical Informatics Stony Brook • Tahsin Kurc PhD Biomedical Informatics Stony Brook Vision – Enable population/epidemiological cancer research that leverages rich cancer phenotype information available from Pathology tissue studies NCIP/Leidos 14X138 and HHSN261200800001E - NCI
  • 9. SEER Virtual Tissue Repository • SEER registries are a potential source of information about unusual outcomes and rare cancers • Leverage Pathology labs which store FFPE tumors, slides and digital images • Link to SEER data – track long term outcomes • Accrue linked clinical data, Pathology slides from SEER sites
  • 10. SEER VIRTUAL TISSUE REPOSITORY • Create linked collection of de-identified clinical data and whole slide images • Extract features from a sample set of images (pancreas and breast cancer). • Enable search, analysis, epidemiological characterization • Pilot focus on extreme outcome Breast Cancer, Pancreatic Cancer cases • Display images and analyzed features
  • 11. Robust Nuclear Segmentation • Robust ensemble algorithm to segment nuclei across tissue types • Optimized algorithm tuning methods • Parameter exploration to optimize quality • Systematic Quality Control pipeline encompassing tissue image quality, human generated ground truth, convolutional neural network critique • Yi Gao, Allen Tannenbaum, Dimitris Samaras, Le Hou, Tahsin Kurc
  • 14. Feature Explorer Suite • Explore Relationship Between Imaging Features, Outcome, ”omics” • Explore relationships between features and explore how features relate to images
  • 15. Feature Explorer - Integrated Pathomics Features, Outcomes and “omics” – TCGA NSCLC Adeno Carcinoma Patients
  • 16. Feature Explorer - Integrated Pathomics Features, Outcomes and “omics” – TCGA NSCLC Adeno Carcinoma Patients
  • 17. Collaboration with MGH – Feature Explorer – Radiology Brain MR/Pathology Features
  • 18. Collaboration with SBU Radiology – TCGA NSCLC Adeno Carcinoma Integrative Radiology, Pathology, “omics”, outcome Mary Saltz, Mark Schweitzer SBU Radiology
  • 19. Pathomics Relationship Between Image and FeaturesLeveraging Visualization to Aid in Feature Management Step 1: Choose a case from the TCGA atlas (case #20) Step 2: Select two features of interest; X axis (area), Y axis (perimeter) Step 3: Zoom in on region of interest Step 4: Pick a specific nucleus of interest. Each dot represents a single nucleus Step 5: Evaluate the features selected in the context of the specific nucleus and where this nucleus is located within the whole slide image The tool provides visual context for feature evaluation. This technique maps both intuitive features (i.e. size, shape, color) and non-intuitive features (i.e. wavelets, texture) to the ground truth of source images through an interactive web-based user interface. Selected nucleus geolocated within whole slide image Detects elongated nucleus Going from the whole slide data set to selected features and back to the image Adding a visual perspective by using a live web-based interactive tool (http://sbu-bmi.github.io/featurescape/u24/Preview.html)
  • 21. Select Feature Pair – dots correspond to nuclei
  • 22. Subregion selected – form of gating analogous to flow cytometry
  • 23. Sample Nuclei from Gated Region
  • 24. Gated Nuclei in Context
  • 25. Algorithm Comparison, Validation, Uncertainty Quantification • High quality image analysis algorithms are essential to support biomedical research and diagnosis • Validate algorithms with human annotations • Compare and consolidate different algorithm results e.g.: what are the distances and overlap ratios between markup boundaries from two algorithms? Green: algorithm 1 Red: algorithm 2 Cross matching of two spatial data sets MICCAI 2014 Brain Tumor Introduction
  • 26. caMicroscope/MongoDB - Multiple Algorithm Comparison; Generate and Curate Pathomics Feature set
  • 28. Heatmap – Depicts Agreement Between Algorithms
  • 29. 3D Slicer Pathology – Generate High Quality Ground Truth
  • 31. Adjust algorithm parameters, manual fine tuning
  • 32. Auto-tuning and feature extraction • Goal – correctly segment trillions of objects (nuclei) • Adjust algorithm parameters • Autotuning – finds parameters that best match ground truth in an image patch • Region template runtime support to optimize generation and management of multi-parameter algorithm results • Eliminates redundant computation, manages locality • Active Harmony – Jeff Hollingsworth!! • Collaboration – George Teodoro, Tahsin Kurc
  • 35. Performance Optimization 256 nodes of Stampede. Each node of the cluster has a dual socket Intel Xeon E5-2680 processors, an Intel Xeon Phi SE10P co-processor and 32GB RAM.The nodes are inter-connected via Mellanox FDR Infiniband switches.
  • 36. Classification • Automated or semi-automated identification of tissue or cell type • Variety of machine learning and deep learning methods • Classification of Neuroblastoma • Classification of Gliomas • Quantification of lymphocyte infiltration
  • 37. Classification and Characterization of Heterogeneity Gurcan, Shamada, Kong, Saltz Hiro Shimada, Metin Gurcan, Jun Kong, Lee Cooper Joel Saltz BISTI/NIBIB Center for Grid Enabled Image Analysis - P20 EB000591, PI Saltz lassification and Characterization of Heterogeneity
  • 38. Neuroblastoma Classification FH: favorable histology UH: unfavorable histology CANCER 2003; 98:2274-81 <5 yr Schwannian Development ≥50% Grossly visible Nodule(s) absent present Microscopic Neuroblastic foci absent present Ganglioneuroma (Schwannian stroma-dominant) Maturing subtype Mature subtype Ganglioneuroblastoma, Intermixed (Schwannian stroma-rich) FH FH Ganglioneuroblastoma, Nodular (composite, Schwannian stroma-rich/ stroma-dominant and stroma-poor) UH/FH* Variant forms* None to <50% Neuroblastoma (Schwannian stroma-poor) Poorly differentiated subtype Undifferentiated subtype Differentiating subtype Any age UH ≥200/5,000 cells Mitotic & karyorrhectic cells 100-200/5,000 cells <100/5,000 cells Any age ≥1.5 yr <1.5 yr UH UH FH ≥200/5,000 cells 100-200/5,000 cells <100/5,000 cells Any age UH ≥1.5 yr <1.5 yr ≥5 yr UH FH UH FH
  • 39. Multi-Scale Machine Learning Based Shimada Classification System • Background Identification • Image Decomposition (Multi-resolution levels) • Image Segmentation (EMLDA) • Feature Construction (2nd order statistics, Tonal Features) • Feature Extraction (LDA) + Classification (Bayesian) • Multi-resolution Layer Controller (Confidence Region) No Yes Image Tile Initialization I = L Background? Label Create Image I(L) Segmentation Feature Construction Feature Extraction Classification Segmentation Feature Construction Feature Extraction Classifier Training Down-sampling Training Tiles Within Confidence Region ? I = I -1 I > 1? Yes Yes No No TRAINING TESTING
  • 41. Brain Tumor Classification – CVPR 2016
  • 43. Brain Tumor Classification Results Le Hou, Dimitris Samaras, Tahsin Kurc, Yi Gao, Liz Vanner, James Davis, Joel Saltz
  • 44. Tumor Infiltrating Lymphocyte quantification • Convolutional neural network to classify lymphocyte infiltration in tissue patches • Convolutional neural network and random forest to classify individual segmented nuclei • Extensive collection of ground truth • Joint work with Emory and TCGA PanCanAtlas Immune group Unsupervised Autoencoder – 100 feature dimensions
  • 46. Receiver Operating Characteristic – Area Under Curve – 95%
  • 47. Lymphocyte Classification Heat Map Trained with 22.2K image patches Pathologist corrects and edits
  • 48. Good Bad Test as Good 2916 33 Test as Bad 28 2094 Machine Learning and Quality Critiquing
  • 49. Dissemination • Containers • Cloud • TCIA • HPC via NSF and DOE • TCGA – PanCanAtlas – Lymphocyte characterization • Integrated Features/NLP joint with TIES
  • 50. ITCR Team Stony Brook University Joel Saltz Tahsin Kurc Yi Gao Allen Tannenbaum Erich Bremer Jonas Almeida Alina Jasniewski Fusheng Wang Tammy DiPrima Andrew White Le Hou Furqan Baig Mary Saltz Emory University Ashish Sharma Adam Marcus Oak Ridge National Laboratory Scott Klasky Dave Pugmire Jeremy Logan Yale University Michael Krauthammer Harvard University Rick Cummings
  • 51. Funding – Thanks! • This work was supported in part by U24CA180924- 01, NCIP/Leidos 14X138 and HHSN261200800001E from the NCI; R01LM011119-01 and R01LM009239 from the NLM • This research used resources provided by the National Science Foundation XSEDE Science Gateways program under grant TG-ASC130023 and the Keeneland Computing Facility at the Georgia Institute of Technology, which is supported by the NSF under Contract OCI-0910735.

Editor's Notes

  • #26: Spatial join/spatial overlay/spatial cross-matching
  • #39: This is Dr. Shimada’s prognosis classfication